NDC 80644-0013

Zegalogue

Dasiglucagon

Zegalogue is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Zealand Pharma A/s. The primary component is Dasiglucagon.

Product ID80644-0013_befd6f41-152c-ca68-e053-2995a90acbc0
NDC80644-0013
Product TypeHuman Prescription Drug
Proprietary NameZegalogue
Generic NameDasiglucagon
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2021-04-05
Marketing CategoryNDA /
Application NumberNDA214231
Labeler NameZealand Pharma A/S
Substance NameDASIGLUCAGON
Active Ingredient Strength1 mg/.6mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 80644-0013-1

1 CONTAINER in 1 PACKAGE (80644-0013-1) > 1 SYRINGE, GLASS in 1 CONTAINER > .6 mL in 1 SYRINGE, GLASS
Marketing Start Date2021-04-05
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Zegalogue" or generic name "Dasiglucagon"

NDCBrand NameGeneric Name
80644-0012Zegaloguedasiglucagon
80644-0013Zegaloguedasiglucagon

Trademark Results [Zegalogue]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZEGALOGUE
ZEGALOGUE
79256691 5905935 Live/Registered
ZEALAND PHARMA A/S
2019-01-14

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.